Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SYNAPTICS Inc Director's Dealing 2015

Oct 28, 2015

31479_dirs_2015-10-27_f461eb1e-63b2-4e2a-a597-746112111ba8.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SYNAPTICS Inc (SYNA)
CIK: 0000817720
Period of Report: 2015-10-23

Reporting Person: McFarland John (SVP, General Counsel & Sec.)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2015-10-23 Common Stock A 4000 $0.00 Acquired 7572 Direct
2015-10-23 Common Stock A 1261 $0.00 Acquired 8833 Direct
2015-10-23 Common Stock F 473 $89.29 Disposed 8360 Direct
2015-10-26 Common Stock M 834 $46.08 Acquired 9194 Direct
2015-10-26 Common Stock S 534 $85.5235 Disposed 8660 Direct
2015-10-26 Common Stock S 300 $86.6367 Disposed 8360 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2015-10-23 Employee Stock Option (Right to Buy) $89.29 A 2725 Acquired 2022-10-23 Common Stock (2725) Direct
2015-10-26 Employee Stock Option (Right to Buy) $46.08 M 834 Disposed 2020-11-04 Common Stock (834) Direct

Footnotes

F1: One-third of the total number of deferred stock units shall vest on each anniversary following the vesting commencement date of 10/31/2015, until fully vested on 10/31/2018.

F2: Reflects shares released October 23, 2015 in connection with the vesting of performance-based market stock units granted on October 24, 2014.

F3: Represents shares of common stock withheld by the Issuer to satisfy certain tax withholding obligations associated with the vesting of performance-based market stock units.

F4: The shares were sold pursuant to a 10b5-1 Trading Plan dated February 19, 2015.

F5: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.00 to $85.99,
inclusive. The reporting person undertakes to provide to Synaptics Incorporated (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F6: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $86.17 to $86.97,
inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F7: 1/12th of the total number of shares subject to the option shall vest and become exercisable each quarter following the October 23, 2015 date of grant, until fully vested on October 23, 2018.

F8: One-third of the total number of shares subject to the option vested and became exercisable on November 4, 2014, and 1/36th of the total number of shares subject to the option vested or shall vest and became or shall become exercisable on the 4th day of each month thereafter until fully vested on November 4, 2016.